Karen Lewis - Net Worth and Insider Trading
Karen Lewis Net Worth
The estimated net worth of Karen Lewis is at least $1 Million dollars as of 2024-11-13. Karen Lewis is the Chief People Officer of Apellis Pharmaceuticals Inc and owns about 46,387 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $1 Million. Details can be seen in Karen Lewis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Lewis has not made any transactions after 2024-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen Lewis
Karen Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Lewis owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Karen Lewis’s form 4 insider trades.
Insider Ownership Summary of Karen Lewis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-01-30 | Chief People Officer |
Karen Lewis Latest Holdings Summary
Karen Lewis currently owns a total of 1 stock. Karen Lewis owns 46,387 shares of Apellis Pharmaceuticals Inc (APLS) as of January 30, 2024, with a value of $1 Million.
Latest Holdings of Karen Lewis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-01-30 | 46,387 | 29.26 | 1,357,284 |
Holding Weightings of Karen Lewis
Karen Lewis Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Lewis has made a total of 10 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 1,250 shares on January 30, 2024, which brought Karen Lewis around $81,400.
Insider Trading History of Karen Lewis
- 1
Karen Lewis Trading Performance
Karen Lewis Ownership Network
Ownership Network List of Karen Lewis
Ownership Network Relation of Karen Lewis
Karen Lewis Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Karen Lewis is the Chief People Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Karen Lewis made 6 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 17,182. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 296,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,263,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,263,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Karen Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Lewis. You might contact Karen Lewis via mailing address: Apellis Pharmaceuticals, Inc., 100 5th Avenue, 3rd Floor, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
